Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
Hosted on MSN2h
Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback